Our study also suggests that targeting Twist could inhibit the interaction between TGF-β and Wnt pathways that could not only prevent breast cancer progressing to EMT and enhancing sensitivity of cancer treatment, but could also inhibit the TGF-β- and Wnt3-induced MMPs and VEGF. This evidence concerns the gene VEGFA and breast carcinoma.